Longitude Capital
Longitude Capital is a venture capital firm specializing in venture growth investments in biotechnology, medical technology, and health solutions companies. The firm focuses on improving clinical outcomes, enhancing patient quality of life, and reducing the cost of care. Since its inception in 2006, Longitude Capital has raised over $2 billion across six funds, demonstrating a strong track record in sourcing, managing, and exiting investments across various market cycles. The firm employs a balanced portfolio strategy, investing in clinical-stage and commercial-stage companies with clinically de-risked assets and favorable valuations. Longitude Capital leverages its extensive industry network and proprietary research to identify new investment opportunities and utilizes a variety of investment structures to optimize returns for stakeholders.
Longitude Capital
2740 Sand Hill Road, 2nd Floor, Menlo Park, CA 94025
What We Do
Longitude Capital works closely with portfolio companies to develop and implement strategic plans, achieve key operating objectives, and build world-class teams.
The firm assists portfolio companies in raising capital and pursuing liquidity opportunities to optimize returns for stakeholders.
Longitude Capital provides operational support to its portfolio companies, helping them achieve technical, clinical, and commercial milestones.
Investment Stage
Portfolio
Focused on nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders.
#Biotechnology
Developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis.
#Biotechnology
Developing imaging and therapeutic molecules for the treatment of solid and hematologic cancers.
#Biotechnology
Developing the LOCOcyteTM cell-therapy platform for continuous local dosing of immunotherapeutics.
#Biotechnology
Developing novel therapies for obesity and metabolic diseases discovered by harnessing the biology of aging.
#Biotechnology
Developing a next-generation IVL (intravascular lithotripsy) device for the minimally invasive treatment of narrowed calcified arteries.
#Medical Technology
Key People
Managing Director
Managing Director
Managing Director
Managing Director
Managing Director and Chief Financial Officer
Managing Director